Clinical Trial: Photodynamic Therapy for Benign Dermal Neurofibromas

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Topical Photodynamic Therapy (PDT) With Levulan® Kerastick® for Benign Dermal Neurofibromas Phase II

Brief Summary:

The investigators wish to determine the time to disease progression for benign neurofibromas treated with Levulan Kerastick topical photosensitizer and red light photodynamic therapy (PDT) in patients with neurofibromatosis type 1 (NF1).

The investigators also wish to measure tumor size for control and treatment tumors in order to gain insights into tumor growth rates.